Efficacy of Buffered Hypertonic Saline(BHS)Nasal Irrigation in Allergic Rhinitis (AR) Children

NCT01441778 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2011-09-28

No results posted yet for this study

Summary

The purpose of this study is to investigate whether buffered hypertonic saline (BHS) is superior to normal saline (NSS) for improving mucociliary function and relief nasal symptoms in children with allergic rhinitis.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

NSS nasal irrigation salt

nasal irrigation twice daily for 4 weeks period

DRUG

BHS nasal irrigation salt

nasal irrigation twice daily for 4 weeks period

Sponsors & Collaborators

  • Thammasat University

    lead OTHER

Principal Investigators

  • Araya Satdhabudh, MD · Thammasat University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01441778 on ClinicalTrials.gov